Funding for AI-supported protein development: Berlin-based startup Exazyme secures €2 million from AIX Ventures and Atlantic Labs.

Exazyme secures €2 million in funding from AIX Ventures and Atlantic Labs, targeting the cumbersome and costly protein development process across various industries. Leveraging AI, Exazyme rapidly identifies optimal proteins from vast datasets, accelerating reactions and performance. Our approach surpasses traditional methods like Directed Evolution. CEO Dr. Ingmar Schuster foresees Exazyme revolutionizing chemical development akin to past computational advances. Richard Socher, AI expert and AIX Ventures founding partner, anticipates Exazyme’s blend of biochemical expertise and advanced algorithms will swiftly deliver top-tier protein development solutions.

Read full article here: 

GOING PUBLIC, 19. Mai 2023

Share This Post